XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenue $ 150,060 $ 132,560 $ 495,978 $ 529,796
Cost of goods sold 114,505 101,774 365,497 374,841
Gross profit 35,555 30,786 130,481 154,955
Operating expenses        
Research and development 23,095 22,578 68,127 65,435
Selling, general and administrative 22,964 22,610 64,611 69,603
Total operating expenses 46,059 45,188 132,738 135,038
Operating income (loss) (10,504) (14,402) (2,257) 19,917
Other income (loss), net 308 (513) (138) (1,432)
Interest income (expense), net 271 5 774 (1,000)
Net income including noncontrolling interest (9,925) (14,910) (1,621) 17,485
Income tax expense 611 2,517 2,643 5,550
Net income (loss) before income (loss) from equity method investment (10,536) (17,427) (4,264) 11,935
Equity method investment income (loss) from equity investee (676) (1,480) (4,085) 1,533
Net income (loss) including noncontrolling interest $ (11,212) $ (18,907) $ (8,349) $ 13,468
Net income (loss) per common share        
Basic (in dollars per share) $ (0.39) $ (0.68) $ (0.30) $ 0.49
Diluted (in dollars per share) $ (0.39) $ (0.68) $ (0.30) $ 0.46
Weighted average number of common shares used to compute net income (loss) per share        
Basic (in shares) 28,433 27,710 28,022 27,537
Diluted (in shares) 28,433 27,710 28,022 29,576